Congress will be compelled to slash Medicaid and Medicare unless a significant portion of the deficit reduction plan currently being developed comprises tax increases, states Henry J. Aaron, PhD, senior fellow of economic studies with the Brookings Institution, in an editorial published in the November 3 issue of The New England Journal of Medicine

Carestream today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the use of its CARESTREAM Vue Motion medical image viewer with mobile devices such as Apple iPads in the U.S.

The Medicare Payment Advisory Commission (MedPAC) has endorsed recommendations to improve enrollment in, along with quality data and the payment method for, the Program of All-Inclusive Care for the Elderly (PACE).

Recent survey findings may indicate that most Americans favor a smaller overall government, but results of a poll released today by the Robert Wood Johnson Foundation and the Harvard School of Public Health show that a majority—52%--truly prefer a “bigger government” that provides more health care services.

Laying the foundation for radiology’s first professional development and leadership academy, the Radiology Leadership Institute ™ (RLI) of the American College of Radiology (ACR) today announced that it has established the RLI Common Body of Knowledge™ (CBK). The RLI CBK provides the framework for delivery of multi-level, in-depth instruction in

While revised from 50% to 25%, multiple procedure payment reductions for imaging interpretation contained in the Medicare final rule released earlier this week by the Centers for Medicare and Medicaid Services (CMS) are "unfounded" and "potentially dangerous", the American College of Radiology (ACR) said today.

CEOs continue to earn higher salaries than their CFO counterparts, but the difference in pay between the two groups is smaller in the health care market than in all other major industries, according to an analysis by BDO USA LLP, a Chicago-based accounting and consulting firm..

Continuing the debate on the “breast density issue”, the National Mammography Quality Assurance Advisory Committee (NMQAAC) of the U.S. Food and Drug Administration (FDA) will convene on Friday to debate whether the latter should require mammography facilities to reveal the presence of breast density in women via reports sent to referring